FREDERICK, Md., Aug. 7 /PRNewswire-FirstCall/-- BioElectronics Corporation, , announced today that Barron Medical, has signed a distribution agreement to provide ActiPatch Therapy to the U.S. ophthalmology market.
Barron Medical, established in 1991 and based in Chino Hills, California, is a distributor of surgical instruments, ultrasound equipment, automated refraction equipment and digital imaging systems. Barron Medical has 31 established, qualified independent sales agents throughout the U.S. and focuses its sales efforts on the ophthalmology market. “Our sales agents are very pleased to introduce the drug-free healing power of ActiPatch to the U.S. ophthalmology market. ActiPatch’s ability to reduce inflammation without the use of drugs, ice or topical ointments will greatly improve the recovery period of our physician’s patients. We expect ActiPatch to be very well received in the ophthalmology market,” said Carlos Barron, President of Barron Medical.
“We are delighted to be associated with Barron Medical. The established relationships they have with ophthalmologic physicians will significantly increase awareness of the therapeutic benefits of ActiPatch Therapy in the ophthalmology market,” said Andrew Whelan, President of BioElectronics Corporation.
About BioElectronics:
BioElectronics Corporation is the maker of ActiPatch(TM). ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.
For more information visit http://www.bioelectronicscorp.com
Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
BioElectronics Corporation
CONTACT: Andrew J. Whelan, President & CEO of BioElectronics Corporation,+1-866-757-2284, Fax: +1-301-874-6935, info@actipatch.net
Web site: http://www.bioelectronicscorp.com//
